Literature DB >> 566109

Radioimmunoassay for fluphenazine in human plasma.

D H Wiles, M Franklin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 566109      PMCID: PMC1429260          DOI: 10.1111/j.1365-2125.1978.tb01636.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  8 in total

Review 1.  The depot fluphenazines: a reappraisal after 10 years' clinical experience.

Authors:  F J Ayd
Journal:  Am J Psychiatry       Date:  1975-05       Impact factor: 18.112

2.  Determination of perphenazine and fluphenazine in whole blood by gas chromatography.

Authors:  N E Larsen; J Naestoft
Journal:  Med Lab Technol       Date:  1973-04

3.  Identification of 7-hydroxyfluphenazine as major metabolite of fluphenazine- 14 C in the dog.

Authors:  J Dreyfuss; A I Cohen
Journal:  J Pharm Sci       Date:  1971-06       Impact factor: 3.534

4.  Antisera highly specific for 17 -oestradiol.

Authors:  D Exley; M W Johnson; P D Dean
Journal:  Steroids       Date:  1971-11       Impact factor: 2.668

5.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

6.  Biological disposition and metabolic fate of fluphenazine- 14 C in the dog and rhesus monkey.

Authors:  J Dreyfuss; J J Ross; E C Schreiber
Journal:  J Pharm Sci       Date:  1971-06       Impact factor: 3.534

7.  A comparative pharmacological study of a series of monohydroxylated and methoxylated chlorpromazine derivatives.

Authors:  A A Manian; D H Efron; M E Goldberg
Journal:  Life Sci       Date:  1965-12       Impact factor: 5.037

8.  Methods for study of fluphenazine kinetics in man.

Authors:  R Whelpton; S H Curry
Journal:  J Pharm Pharmacol       Date:  1976-12       Impact factor: 3.765

  8 in total
  15 in total

1.  Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.

Authors:  D H Wiles; M G Gelder
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335

2.  Kinetics of oral fluphenazine disposition in humans by GC-MS.

Authors:  K K Midha; G McKay; R Edom; E D Korchinski; E M Hawes; K Hall
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

3.  A depot neuroleptic withdrawal study. Plasma concentration of fluphenazine and flupenthixol and relapse frequency.

Authors:  B Wistedt; A Jørgensen; D Wiles
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

4.  Pharmacokinetics of haloperidol and fluphenazine decanoates in chronic schizophrenia.

Authors:  D H Wiles; R G McCreadie; A Whitehead
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Plasma levels of fluphenazine and prolactin in psychiatric patients.

Authors:  T Kitamura; D A McGovern; N W Imlah; D Wiles; A A Schiff
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988-09

6.  Blood and plasma kinetics of cis(Z)-clopenthixol and fluphenazine in psychiatric patients after intramuscular injection of their decanoic esters.

Authors:  A Viala; N Hou; B Ba; A Durand; H Dufour; N D'Agostino; C Berda; A Jørgensen
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Variation in oro-facial tardive dyskinesia during depot antipsychotic drug treatment.

Authors:  T R Barnes; D H Wiles
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

8.  Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man.

Authors:  S H Curry; R Whelpton; P J de Schepper; S Vranckx; A A Schiff
Journal:  Br J Clin Pharmacol       Date:  1979-04       Impact factor: 4.335

9.  Plasma levels of perphenazine (Trilafon) related to development of extrapyramidal side effects.

Authors:  L B Hansen; N E Larsen; P Vestergård
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

10.  A depot neuroleptic withdrawal study neurological effects.

Authors:  B Wistedt; D Wiles; A Jørgensen
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.